Stryker Corporation $SYK Stake Boosted by LVM Capital Management Ltd. MI

by · The Cerbat Gem

LVM Capital Management Ltd. MI increased its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 1.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 37,890 shares of the medical technology company’s stock after purchasing an additional 695 shares during the quarter. Stryker accounts for about 1.6% of LVM Capital Management Ltd. MI’s investment portfolio, making the stock its 18th largest holding. LVM Capital Management Ltd. MI’s holdings in Stryker were worth $14,991,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Park National Corp OH lifted its stake in Stryker by 0.7% in the second quarter. Park National Corp OH now owns 47,723 shares of the medical technology company’s stock valued at $18,881,000 after buying an additional 345 shares during the last quarter. Harbor Investment Advisory LLC lifted its stake in Stryker by 4.3% in the second quarter. Harbor Investment Advisory LLC now owns 8,155 shares of the medical technology company’s stock valued at $3,226,000 after buying an additional 336 shares during the last quarter. AG2R LA Mondiale Gestion D Actifs bought a new stake in Stryker in the first quarter valued at $4,896,000. Swedbank AB lifted its stake in Stryker by 0.9% in the first quarter. Swedbank AB now owns 113,236 shares of the medical technology company’s stock valued at $42,152,000 after buying an additional 995 shares during the last quarter. Finally, Voya Investment Management LLC lifted its stake in Stryker by 22.6% in the first quarter. Voya Investment Management LLC now owns 866,386 shares of the medical technology company’s stock valued at $322,417,000 after buying an additional 159,662 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Citigroup reiterated a “buy” rating and issued a $455.00 target price (up from $443.00) on shares of Stryker in a research note on Thursday, May 22nd. Evercore ISI raised their target price on Stryker from $390.00 to $415.00 and gave the company an “outperform” rating in a research note on Tuesday, July 8th. Wells Fargo & Company raised their price target on Stryker from $435.00 to $445.00 and gave the company an “overweight” rating in a report on Friday, August 1st. BTIG Research reissued a “buy” rating on shares of Stryker in a report on Monday, July 14th. Finally, Needham & Company LLC raised their price target on Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a report on Friday, August 1st. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $431.42.

Get Our Latest Stock Analysis on Stryker

Insider Transactions at Stryker

In related news, insider Viju Menon sold 500 shares of Stryker stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the transaction, the insider directly owned 12,511 shares of the company’s stock, valued at $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. The trade was a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is owned by insiders.

Stryker Price Performance

NYSE:SYK opened at $383.32 on Friday. The business’s 50-day moving average price is $388.98 and its 200 day moving average price is $379.65. The firm has a market cap of $146.55 billion, a P/E ratio of 50.77, a PEG ratio of 2.80 and a beta of 0.93. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70.

Stryker (NYSE:SYK – Get Free Report) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.07 by $0.06. The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker’s revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the company earned $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, sell-side analysts predict that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker’s payout ratio is presently 44.50%.

Stryker Profile

(Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Featured Articles

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).